Harbor Capital Advisors Inc. Purchases 111,721 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Harbor Capital Advisors Inc. lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 23.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 586,443 shares of the company's stock after buying an additional 111,721 shares during the period. Harbor Capital Advisors Inc. owned about 0.43% of AdaptHealth worth $6,357,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC lifted its stake in AdaptHealth by 361.3% in the third quarter. Barclays PLC now owns 181,240 shares of the company's stock valued at $2,034,000 after purchasing an additional 141,949 shares during the last quarter. Janus Henderson Group PLC grew its position in AdaptHealth by 42.9% in the fourth quarter. Janus Henderson Group PLC now owns 38,298 shares of the company's stock worth $364,000 after acquiring an additional 11,500 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in shares of AdaptHealth during the 4th quarter valued at about $229,000. Proficio Capital Partners LLC purchased a new stake in shares of AdaptHealth in the 4th quarter valued at $181,000. Finally, Nuveen Asset Management LLC increased its holdings in shares of AdaptHealth by 27.9% in the fourth quarter. Nuveen Asset Management LLC now owns 316,108 shares of the company's stock worth $3,009,000 after buying an additional 69,050 shares during the period. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Stock Performance

Shares of NASDAQ:AHCO traded down $0.20 during trading on Friday, hitting $8.60. The company's stock had a trading volume of 881,565 shares, compared to its average volume of 1,287,026. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.90. The firm has a market cap of $1.16 billion, a price-to-earnings ratio of -5.21, a P/E/G ratio of 1.08 and a beta of 1.64. The company has a 50-day moving average of $8.67 and a 200-day moving average of $9.52.

Analyst Upgrades and Downgrades

AHCO has been the subject of a number of recent analyst reports. Truist Financial lowered their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Royal Bank of Canada lowered their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Finally, Canaccord Genuity Group boosted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.